Filters

ASF1A Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)

ASF1A Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) size: 1.0 µg DNA 322

Supplier ABM LENTIVECTORS
Price 322
Size 1.0 µg DNA
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
DNA lentivector for transduction information GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetASF1A Lentiviral Vector (EF1a) (pLenti-GIII-EF1a)
Short nameASF1A Lentiviral Vector ( ) (EF1a) (pLenti-GIII-EF1a)
TechniqueVectors
Species Humans, Human
Alternative name sapiens) (EF1a) (pLenti-GIII-EF1a), ASF1A Lentiviral integrating Desoxyribonucleic acid sequence (H
Identity 20995
Gene ASF1A
Long gene name anti-silencing function 1A histone chaperone
Synonyms gene name ASF1 anti-silencing function 1 homolog A (S, cerevisiae)
Synonyms DKFZP547E2110 CIA
Locus 6q22, 31
Discovery year 2003-05-01
GenBank acession AF279306
Entrez gene record 25842
Pubmed identfication 10810093 11042152
RefSeq identity NM_014034
Havana BLAST/BLAT OTTHUMG00000015470

Similar products

Subscribe to our Newsletter